These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gene transfer as an approach to treating hemophilia. High KA Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573 [TBL] [Abstract][Full Text] [Related]
4. Gene transfer as an approach to treating hemophilia. High KA Circ Res; 2001 Feb; 88(2):137-44. PubMed ID: 11157664 [TBL] [Abstract][Full Text] [Related]
5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy for the hemophilias. Walter J; High KA Adv Vet Med; 1997; 40():119-34. PubMed ID: 9395731 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy strategies for hemophilia: benefits versus risks. Petrus I; Chuah M; VandenDriessche T J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648. Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531 [TBL] [Abstract][Full Text] [Related]
9. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Wahlfors JJ; Morgan RA Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551 [TBL] [Abstract][Full Text] [Related]
13. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies. Van Damme A; Chuah MK; Collen D; VandenDriessche T Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930 [TBL] [Abstract][Full Text] [Related]
14. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for the haemophilias: current status. Hoeben RC Biologicals; 1995 Mar; 23(1):27-9. PubMed ID: 7619431 [No Abstract] [Full Text] [Related]
16. State and prospects of gene therapy for the hemophilias. Fallaux FJ; Hoeben RC; Briƫt E Thromb Haemost; 1995 Jul; 74(1):266-73. PubMed ID: 8578470 [No Abstract] [Full Text] [Related]
17. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Chuah MK; VandenDriessche T; Morgan RA Hum Gene Ther; 1995 Nov; 6(11):1363-77. PubMed ID: 8573610 [TBL] [Abstract][Full Text] [Related]
18. Advances and challenges for hemophilia gene therapy. Batty P; Lillicrap D Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444 [TBL] [Abstract][Full Text] [Related]
19. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507 [TBL] [Abstract][Full Text] [Related]
20. Parvovirus-mediated gene transfer for the haemophilias. Walsh CE; Chao H Haemophilia; 2002 Mar; 8 Suppl 2():60-7. PubMed ID: 11966856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]